A detailed history of Kellner Capital, LLC transactions in Karuna Therapeutics, Inc. stock. As of the latest transaction made, Kellner Capital, LLC holds 4,100 shares of KRTX stock, worth $0. This represents 2.34% of its overall portfolio holdings.

Number of Shares
4,100
Holding current value
$0
% of portfolio
2.34%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

BUY
$161.01 - $317.85 $660,141 - $1.3 Million
4,100 New
4,100 $1.3 Million

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Kellner Capital, LLC Portfolio

Follow Kellner Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kellner Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kellner Capital, LLC with notifications on news.